Listed

ImageneBio, Inc.

IMANasdaqCIK 1835579HealthcareFiscal year ends Dec 31

Reports and events: 98 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

ImageneBio, Inc., Reports and events
FiledFormWhat it isAccession number
2024-05-2816:24 ET8-K2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-148112
2024-05-1316:33 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-058715
2024-04-2616:22 ETDEF 14AProxy statementPeriod 2024-06-070001140361-24-022470
2024-03-1207:30 ET10-KAnnual reportPeriod 2023-12-310000950170-24-029651
2024-02-2116:29 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-041504
2024-01-1816:26 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-010227
2023-11-0907:30 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061535
2023-11-0907:09 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-061519
2023-10-1117:10 ET8-K5.07 Shareholder vote results0001140361-23-047880
2023-09-2516:05 ETDEF 14AProxy statementPeriod 2023-10-110001140361-23-045091
2023-09-2116:52 ETSC 13D/AOwnership report, active investor, amended0000947871-23-000950
2023-09-1416:21 ETSC 13D/AOwnership report, active investor, amended0000947871-23-000929
2023-08-1007:00 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-040943
2023-08-0708:02 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-204493
2023-06-3017:15 ET8-K3.01 Delisting notice0001193125-23-180591
2023-06-0916:26 ET8-K5.07 Shareholder vote results0001193125-23-164481
2023-05-1509:09 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-144274
2023-05-1506:04 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021909
2023-04-2808:17 ETDEF 14AProxy statementPeriod 2023-06-090001193125-23-124483
2023-04-1709:14 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-103005
2023-03-1406:04 ET10-KAnnual reportPeriod 2022-12-310000950170-23-007681
2022-12-1916:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-308371
2022-11-2808:18 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-292953
2022-11-1009:11 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-282059
2022-11-0707:31 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-022323
2022-08-1106:03 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016600
2022-06-1007:46 ET8-K5.07 Shareholder vote results0001193125-22-171517
2022-05-1206:02 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-009446
2022-04-2716:32 ETDEF 14AProxy statementPeriod 2022-06-090001193125-22-123712
2022-04-1307:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-103598
2022-04-0607:04 ET8-K8.01 Other events0001193125-22-096765
2022-03-1706:31 ET10-KAnnual reportPeriod 2021-12-310000950170-22-003998
2022-02-2416:43 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-052216
2022-02-1117:12 ETSC 13DOwnership report, active investor0001387131-22-001711
2022-01-2807:23 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-020673
2022-01-2607:26 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-017680
2021-11-1016:39 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-326102
2021-11-1006:05 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-003871
2021-08-1616:45 ETSC 13D/AOwnership report, active investor, amended0000947871-21-000939
2021-08-1216:21 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-043997
2021-08-1210:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-043726
2021-05-1316:15 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-027555
2021-05-1307:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-159837
2021-04-1507:43 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-117138
2021-04-1519:31 ETSC 13DOwnership report, active investor0000947871-21-000427
2021-03-3016:48 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-21-100292
2021-03-2208:51 ETS-1/ARegistration statement, amended0001193125-21-088609
2021-03-0514:59 ETS-1Registration statement0001193125-21-071313

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:13 ET. Listed shows no prices and gives no investment advice.